i
HIV Testing Among Transgender Women and Men — 27 States and Guam, 2014–2015
-
Aug 25 2017
Source: MMWR Morb Mortal Wkly Rep. 66(33):883-887. -
Alternative Title:MMWR Morb Mortal Wkly Rep
-
Publisher's site:
-
Personal Author:
-
Description:Transgender persons are at high risk for human immunodeficiency Virus (HIV) infection; in a recent Analysis of the results of over nine million CDC funded HIV tests, transgender women* had the highest percentage of confirmed positive results (2.7%) of any gender category (1). Transgender men,| particularly those who have sex with cisgender| men, are also at high risk for infection (2). HIV tTesting is critical for detecting and treating persons who are infected and delivering preventive services to those who are uninfected. CDC recommends that persons at high risk for HIV infection be screened for HIV at least annually, although transgender persons are not specified in the current recommendations. CDC analyzed data from the Behavioral Risk Factor Surveillance System (BRFSS) to describe HIV tTesting among transgender women and men and two cisgender comparison groups in 27 states and Guam. After adjusting for demographic characteristics, transgender women and men had a lower prevalence of ever tTesting and past year tTesting for HIV (35.6% and 31.6% ever, and 10.0% and 10.2% past year, respectively) compared with cisgender gay and bisexual men (61.8% ever and 21.6% past year) and instead reported tTesting at levels comparable to cisgender heterosexual men and women (35.2% ever, and 8.6% past year). This finding suggests that transgender women and men might not be sufficiently reached by current HIV tTesting measures. Tailoring HIV tTesting activities to overcome the unique barriers faced by transgender women and men might increase rates of tTesting among these populations.
-
Subjects:
-
Pubmed ID:28837547
-
Pubmed Central ID:PMC5687817
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: